Your browser doesn't support javascript.
loading
Luteolin intake is negatively associated with all-cause and cardiac mortality among patients with type 2 diabetes mellitus.
Zhang, Wenbin; Li, Duanbin; Shan, Yu; Tao, Yecheng; Chen, Qingqing; Hu, Tianli; Gao, Menghan; Chen, Zhezhe; Jiang, Hangpan; Du, Changqin; Wang, Min; Guo, Kai.
Affiliation
  • Zhang W; Department of Cardiology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
  • Li D; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, Zhejiang, People's Republic of China.
  • Shan Y; Department of Cardiology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
  • Tao Y; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, Zhejiang, People's Republic of China.
  • Chen Q; Department of Cardiology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
  • Hu T; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, Zhejiang, People's Republic of China.
  • Gao M; Department of Cardiology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
  • Chen Z; Key Laboratory of Cardiovascular Intervention and Regenerative Medicine of Zhejiang Province, Hangzhou, Zhejiang, People's Republic of China.
  • Jiang H; Department of Cardiology, Zhejiang Hospital, Hangzhou, Zhejiang, People's Republic of China.
  • Du C; Department of Cardiology, The Fourth Affiliated Hospital, College of Medicine, Zhejiang University, Yiwu, Zhejiang, People's Republic of China.
  • Wang M; College of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
  • Guo K; Department of Cardiology, Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang, People's Republic of China.
Diabetol Metab Syndr ; 15(1): 59, 2023 Mar 25.
Article in En | MEDLINE | ID: mdl-36966325

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Diabetol Metab Syndr Year: 2023 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Diabetol Metab Syndr Year: 2023 Document type: Article Country of publication: